<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0031">
 <label>31.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Loi</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Michiels</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Salgado</surname>
   <given-names>R</given-names>
  </string-name>, et al. 
  <article-title>Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial</article-title>. 
  <source>
   <italic toggle="yes">Ann Oncol</italic>
  </source>. 
  <year>2014</year>;
  <volume>25</volume>(
  <issue>8</issue>):
  <fpage>1544</fpage>â€“
  <lpage>1550</lpage>. doi:
  <pub-id pub-id-type="doi">10.1093/annonc/mdu112</pub-id>
  <pub-id pub-id-type="pmid">24608200</pub-id>
 </mixed-citation>
</ref>
